Unimed, Amil and colossal purchase of a competitor involving R$ 120 MILLION: controversy!

Some time ago, there was the purchase of a rival from Unimed whose intention was to eliminate Amil, a competitor of the first health plan.

A few years ago, a giant in the healthcare sector took a big step in its expansion and innovation trajectory. At the time, this symbolized quite a change in the sector.

With the purchase of Sistemas e Planos de Saúde for no less than R$120 million, the company reaffirms its commitment to offering quality and accessible services to everyone. See below!

Unimed and Amil were protagonists of an important change in health plans some time ago. Remember the event! / Source: disclosure

A strategic partnership

The acquisition, carried out by the subsidiary Notre Dame Intermédica Saúde, was not just a financial transaction, but a strategic union that aimed to expand the offer of quality health services at affordable costs.

Furthermore, the payment, made in cash, took into account debt and working capital adjustments, in addition to a portion reserved to cover possible contingencies.

The impact of Sistemas on the market

Sistemas is not just any operator. With an impressive net revenue of approximately R$79 million in the 12 months prior to July 2022 and a cash loss ratio of 73.4%, it stands out in the low-cost healthcare market.

Its focus is on offering quality health plans to around 77 thousand beneficiaries, located mainly in the vibrant city of São Paulo and neighboring municipalities such as Osasco, Guarulhos, Embu and Cotia.

See more: Will health plans be CHANGED? Understand who may be affected in 2024

Synergies and growth

But what really made this acquisition special? In short, Hapvida, which is a great rival of Unimed, saw this partnership as a unique opportunity to accelerate Sistemas’ growth in all its areas of activity.

Furthermore, the integration promises to capture administrative and assistance synergies. This means greater efficiency and quality in patient care, in regions where Hapvida already has a broad structure of its own medical and hospital care network.

In summary, the verticalization of services is a growing trend in the healthcare sector, and this acquisition perfectly aligns with this strategy, promising to bring tangible benefits to both patients and the company’s operations.

Unimed discontinued several accreditations

Returning to the present day, Unimed decided to discontinue its services in 37 hospitals throughout the DF and 4 other states, including São Paulo, Bahia, Rio de Janeiro and Maranhão.

This discontinuation mainly affects emergency care, especially during the dengue outbreak that is ravaging the country. According to information from Jornal Metrópoles, services end on March 4th.

Dengue outbreak in Brazil

According to information from the Ministry of Health, there were probably records of around 512,353 cases of dengue in Brazil this year alone. Regarding deaths, 75 were confirmed, while another 340 are still under investigation.

Discontinuation of Unimed plans

Furthermore, some hospitals, such as Hospital Anna Nery and also Hospital do Coração, should no longer provide services through family and individual plans. The same goes for collective subscription plans, for small or medium-sized companies and businesses.

In São Paulo, the hospitals that received deaccreditation were Defeitos da Face, Paranaguá, Albert Sabin, Dom Antonio de Alvarenga, Hospital Presidente, Hospital Santa Clara, Hospital Vidas, Impar Serviços Hospitalares Filial Santa Paula, Santa Rita, Hospital São Paulo and Leforte Kids.

Namely, Jornal Metrópoles even tried to contact Unimed for answers, but, until the publication of the article, it had not received a response.

See more: Health plans have a new rival: no waiting period, no adjustment and for less than R$30!

Post a Comment

Previous Post Next Post